Empagliflozin Trims Liver Fat in Patients With T2D and NAFLD

Dr Kuchay discusses his findings from the E-LIFT study.

//www.medscape.com/viewarticle/894840

Source: Medscape Diabetes & Endocrinology Podcast - April 9, 2018 Category: Endocrinology Authors: Medscape Source Type: podcasts

More News: Diabetes | Empagliflozin | Endocrinology | Jardiance | Liver | Non-alcoholic Fatty Liver Diseases (NAFLD) | Podcasts | Study | Urology & Nephrology